# Aprecia Pharmaceuticals LLC – FDA Inspection, Mar 21, 2025

Source: https://www.keypedia.com/records/fda_inspections/aprecia-pharmaceuticals-llc/47a24c0c-b6f4-4239-a0a2-56c8eeb394e0
Source feed: FDA_Inspections

> FDA inspection 1264269 of Aprecia Pharmaceuticals LLC, March 21, 2025. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1264269
- Company Name: Aprecia Pharmaceuticals LLC
- Inspection Date: 2025-03-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Cincinnati District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1092472 - 2019-05-23
- FDA Inspection 1054779 - 2018-05-23
- FDA Inspection 1030116 - 2017-10-03

## Related Officers

- [Investigator](https://www.keypedia.com/people/martin-m-kimani/fbc296cc-e80e-46f4-a34a-848c8b20da05)
- [FDA Associated Person](https://www.keypedia.com/people/rafeeq-a-habeeb/ac58c0b7-bd42-4037-8ccb-bf0351b7744f)

Company: https://www.keypedia.com/companies/aprecia-pharmaceuticals-llc/126049a3-6c3d-4616-8d44-006827a308c3

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22